ARTV · Artiva Biotherapeutics, Inc.

Summary

Artiva Biotherapeutics, Inc. filed an 8-K on February 19, 2026, with Item 5.02 disclosure regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, referencing an event on February 1. Specific details of the changes were not provided in the document content.

Key takeaways

• Item 5.02 disclosure
• Event referenced on February 1
• Filing date: 2026-02-19